OAF Blocks SIAH1-Mediated Degradation of SCPX, a Therapeutic Strategy for MASLD.
Summary withdrawn
TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.
masld
fatty-liver-disease
lipid-metabolism
oaf
scpx
siah1